Bisphenol a
CAS 80-05-7
Bisphenol a (CAS 80-05-7) is a pharmaceutical compound with 6 bioactivity targets and 0 adverse event associations.
Compound Identity
Matched identifiers and naming fields for the pharmaceutical compound record.
Cross-Reference to Cosmetics
Same-CAS ingredient record found in the cosmetics vertical.
Bioactivity & Target Interactions
Target-level activity records with assay counts, activity type, and measured value where present.
| Target | Activity | Value | Assays | Organism |
|---|---|---|---|---|
| - | IC50 | 14357.855142857143 nM | 35 | - |
| - | Potency | 25693.034090909092 nM | 29 | - |
| - | EC50 | 2438.8333333333335 nM | 6 | - |
| - | Ki | 11347.5 nM | 6 | - |
| - | AC50 | 68196.03333333334 nM | 3 | - |
| - | Kd | 5.5 nM | 1 | - |
IUPHAR Ligand-Target Data
Curated ligand-target interaction rows with action, affinity, and literature identifiers.
| Target | Action | Affinity | PubMed |
|---|---|---|---|
| Androgen receptor AR |
Antagonist | 5.230000019073486 pIC50 | 23768907 |
| Estrogen receptor-β ESR2 |
Partial agonist | 5.960000038146973 pEC50 | 23768907 |
Drug Names / RxNorm
Normalized drug-name vocabulary rows, RxCUIs, and source abbreviations.
| Name | RxCUI | Type | Source |
|---|---|---|---|
| BISPHENOL A | 1433347 | SU | MTHSPL |
| bisphenol A | 1433347 | IN | RXNORM |
Frequently Asked Questions
Short answers generated only from the same visible source-linked rows on this page.
What is Bisphenol a used for in pharmaceutical contexts?
Bisphenol a (CAS 80-05-7) is rendered as a pharmaceutical compound from the matched source rows; no DailyMed product-name rows are present in this page query.
What are the known adverse events for Bisphenol a?
No adverse-event association or SIDER side-effect rows are rendered for Bisphenol a in this page query. Signal rows are source-linked records and should not be read as incidence rates or causality conclusions.
Is Bisphenol a also used in cosmetics?
Yes. The ingredients table has a same-CAS cosmetic profile for 4,4'-Isopropylidenediphenol (Bisphenol A / BPA) with EU status "prohibited".
What clinical phase is Bisphenol a in?
No phase 1-4 clinical development badge is rendered for Bisphenol a because the matched compound identifier rows do not contain a max-phase value.